APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrin Alpha V

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Integrin Alpha V Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchIntegrin Alpha V Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Alpha V Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Integrin Alpha V Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Alpha V Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Alpha V Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Integrin Alpha V market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Integrin Alpha V is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Integrin Alpha V is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Integrin Alpha V is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Integrin Alpha V is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Integrin Alpha V include Merck & Co Inc, Biogen Inc, Vascular Pharmaceuticals Inc, SciFluor Life Sciences LLC, Morphic Therapeutic Inc, Merck KGaA, MedImmune LLC, Factor Therapeutics Ltd and BioMAS Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Integrin Alpha V, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Integrin Alpha V, also provides the revenue of main regions and countries. Of the upcoming market potential for Integrin Alpha V, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Integrin Alpha V revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Integrin Alpha V market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Integrin Alpha V revenue, projected growth trends, production technology, application and end-user industry.

Integrin Alpha V Segment by Company

Merck & Co Inc

Biogen Inc

Vascular Pharmaceuticals Inc

SciFluor Life Sciences LLC

Morphic Therapeutic Inc

Merck KGaA

MedImmune LLC

Factor Therapeutics Ltd

BioMAS Ltd

Integrin Alpha V Segment by Type

MK-0429

C-16Y

AC-301

264-RAD

Others

Integrin Alpha V Segment by Application

Ophthalmology

Respiratory

Metabolic Disorders

Infectious Disease

Others

Integrin Alpha V Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha V market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha V and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha V.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Integrin Alpha V in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Integrin Alpha V company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Integrin Alpha V revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Integrin Alpha V Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. MK-0429 Major Player Table 3. C-16Y Major Player Table 4. AC-301 Major Player Table 5. 264-RAD Major Player Table 6. Others Major Player Table 7. Global Integrin Alpha V Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Ophthalmology Major Player Table 9. Respiratory Major Player Table 10. Metabolic Disorders Major Player Table 11. Infectious Disease Major Player Table 12. Others Major Player Table 13. Integrin Alpha V Industry Trends Table 14. Integrin Alpha V Industry Drivers Table 15. Integrin Alpha V Industry Opportunities and Challenges Table 16. Integrin Alpha V Industry Restraints Table 17. Global Integrin Alpha V Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Integrin Alpha V Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Integrin Alpha V Market Share by Region (2021-2026) Table 20. Global Integrin Alpha V Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Integrin Alpha V Market Share by Region (2027-2032) Table 22. Global Integrin Alpha V Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Integrin Alpha V Revenue Market Share by Players (2021-2026) Table 24. Global Integrin Alpha V Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Integrin Alpha V Key Players Headquarters & Area Served Table 26. Global Integrin Alpha V Players, Product Type & Application Table 27. Global Integrin Alpha V Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Integrin Alpha V by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Integrin Alpha V Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Integrin Alpha V Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Integrin Alpha V Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Integrin Alpha V Revenue Market Share by Type (2021-2026) Table 34. Global Integrin Alpha V Revenue Market Share by Type (2027-2032) Table 35. Global Integrin Alpha V Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Integrin Alpha V Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Integrin Alpha V Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Integrin Alpha V Revenue Market Share by Application (2021-2026) Table 39. Global Integrin Alpha V Revenue Market Share by Application (2027-2032) Table 40. Merck & Co Inc Company Information Table 41. Merck & Co Inc Business Overview Table 42. Merck & Co Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck & Co Inc Integrin Alpha V Product Portfolio Table 44. Merck & Co Inc Recent Development Table 45. Biogen Inc Company Information Table 46. Biogen Inc Business Overview Table 47. Biogen Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Biogen Inc Integrin Alpha V Product Portfolio Table 49. Biogen Inc Recent Development Table 50. Vascular Pharmaceuticals Inc Company Information Table 51. Vascular Pharmaceuticals Inc Business Overview Table 52. Vascular Pharmaceuticals Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio Table 54. Vascular Pharmaceuticals Inc Recent Development Table 55. SciFluor Life Sciences LLC Company Information Table 56. SciFluor Life Sciences LLC Business Overview Table 57. SciFluor Life Sciences LLC Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio Table 59. SciFluor Life Sciences LLC Recent Development Table 60. Morphic Therapeutic Inc Company Information Table 61. Morphic Therapeutic Inc Business Overview Table 62. Morphic Therapeutic Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Morphic Therapeutic Inc Integrin Alpha V Product Portfolio Table 64. Morphic Therapeutic Inc Recent Development Table 65. Merck KGaA Company Information Table 66. Merck KGaA Business Overview Table 67. Merck KGaA Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Merck KGaA Integrin Alpha V Product Portfolio Table 69. Merck KGaA Recent Development Table 70. MedImmune LLC Company Information Table 71. MedImmune LLC Business Overview Table 72. MedImmune LLC Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. MedImmune LLC Integrin Alpha V Product Portfolio Table 74. MedImmune LLC Recent Development Table 75. Factor Therapeutics Ltd Company Information Table 76. Factor Therapeutics Ltd Business Overview Table 77. Factor Therapeutics Ltd Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Factor Therapeutics Ltd Integrin Alpha V Product Portfolio Table 79. Factor Therapeutics Ltd Recent Development Table 80. BioMAS Ltd Company Information Table 81. BioMAS Ltd Business Overview Table 82. BioMAS Ltd Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. BioMAS Ltd Integrin Alpha V Product Portfolio Table 84. BioMAS Ltd Recent Development Table 85. North America Integrin Alpha V Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Integrin Alpha V Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Integrin Alpha V Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Integrin Alpha V Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Integrin Alpha V Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Integrin Alpha V Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Integrin Alpha V Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Integrin Alpha V Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Integrin Alpha V Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Integrin Alpha V Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Integrin Alpha V Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Integrin Alpha V Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Integrin Alpha V Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Integrin Alpha V Revenue by Country (US$ Million) & (2027-2032) Table 99. China Integrin Alpha V Revenue by Type (2021-2026) & (US$ Million) Table 100. China Integrin Alpha V Revenue by Type (2027-2032) & (US$ Million) Table 101. China Integrin Alpha V Revenue by Application (2021-2026) & (US$ Million) Table 102. China Integrin Alpha V Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Integrin Alpha V Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Integrin Alpha V Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Integrin Alpha V Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Integrin Alpha V Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Integrin Alpha V Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Integrin Alpha V Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Integrin Alpha V Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Integrin Alpha V Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Integrin Alpha V Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Integrin Alpha V Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Integrin Alpha V Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Integrin Alpha V Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Integrin Alpha V Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Integrin Alpha V Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Integrin Alpha V Image Figure 2. Global Integrin Alpha V Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrin Alpha V Market Size Share 2021 VS 2025 VS 2032 Figure 4. MK-0429 Image Figure 5. C-16Y Image Figure 6. AC-301 Image Figure 7. 264-RAD Image Figure 8. Others Image Figure 9. Global Integrin Alpha V Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Integrin Alpha V Market Size Share 2021 VS 2025 VS 2032 Figure 11. Ophthalmology Image Figure 12. Respiratory Image Figure 13. Metabolic Disorders Image Figure 14. Infectious Disease Image Figure 15. Others Image Figure 16. Global Integrin Alpha V Market Size (US$ Million) & (2021-2032) Figure 17. Global Integrin Alpha V Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Integrin Alpha V Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Integrin Alpha V Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Integrin Alpha V Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Integrin Alpha V Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Integrin Alpha V Revenue Market Share by Type (2021-2032) Figure 24. Global Integrin Alpha V Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Integrin Alpha V Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Integrin Alpha V Revenue Market Share by Application (2021-2032) Figure 27. North America Integrin Alpha V Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Integrin Alpha V Revenue Share by Type (2021-2032) Figure 29. North America Integrin Alpha V Revenue Share by Application (2021-2032) Figure 30. North America Integrin Alpha V Revenue Share by Country (2021-2032) Figure 31. United States Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Integrin Alpha V Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Integrin Alpha V Revenue Share by Type (2021-2032) Figure 36. Europe Integrin Alpha V Revenue Share by Application (2021-2032) Figure 37. Europe Integrin Alpha V Revenue Share by Country (2021-2032) Figure 38. Germany Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Integrin Alpha V Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Integrin Alpha V Revenue Share by Type (2021-2032) Figure 48. China Integrin Alpha V Revenue Share by Application (2021-2032) Figure 49. Asia Integrin Alpha V Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Integrin Alpha V Revenue Share by Type (2021-2032) Figure 51. Asia Integrin Alpha V Revenue Share by Application (2021-2032) Figure 52. Asia Integrin Alpha V Revenue Share by Region (2021-2032) Figure 53. Japan Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Integrin Alpha V Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Integrin Alpha V Revenue Share by Type (2021-2032) Figure 61. SAMEA Integrin Alpha V Revenue Share by Application (2021-2032) Figure 62. SAMEA Integrin Alpha V Revenue Share by Country (2021-2032) Figure 63. Brazil Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Integrin Alpha V Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • MK-0429
  • C-16Y
  • AC-301
  • 264-RAD
  • Others
Applications
  • Ophthalmology
  • Respiratory
  • Metabolic Disorders
  • Infectious Disease
  • Others
Companies covered
  • Merck & Co Inc
  • Biogen Inc
  • Vascular Pharmaceuticals Inc
  • SciFluor Life Sciences LLC
  • Morphic Therapeutic Inc
  • Merck KGaA
  • MedImmune LLC
  • Factor Therapeutics Ltd
  • BioMAS Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Integrin Alpha V Market by Type
  3. 1.2.1 Global Integrin Alpha V Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 MK-0429
  5. 1.2.3 C-16Y
  6. 1.2.4 AC-301
  7. 1.2.5 264-RAD
  8. 1.2.6 Others
  9. 1.3 Integrin Alpha V Market by Application
  10. 1.3.1 Global Integrin Alpha V Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Ophthalmology
  12. 1.3.3 Respiratory
  13. 1.3.4 Metabolic Disorders
  14. 1.3.5 Infectious Disease
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Integrin Alpha V Market Dynamics
  1. 2.1 Integrin Alpha V Industry Trends
  2. 2.2 Integrin Alpha V Industry Drivers
  3. 2.3 Integrin Alpha V Industry Opportunities and Challenges
  4. 2.4 Integrin Alpha V Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Integrin Alpha V Market Perspective (2021-2032)
  2. 3.2 Global Integrin Alpha V Growth Trends by Region
  3. 3.2.1 Global Integrin Alpha V Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Integrin Alpha V Market Size by Region (2021-2026)
  5. 3.2.3 Global Integrin Alpha V Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Integrin Alpha V Revenue by Players
  2. 4.1.1 Global Integrin Alpha V Revenue by Players (2021-2026)
  3. 4.1.2 Global Integrin Alpha V Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Integrin Alpha V Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Integrin Alpha V Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Integrin Alpha V Key Players Headquarters & Area Served
  7. 4.4 Global Integrin Alpha V Players, Product Type & Application
  8. 4.5 Global Integrin Alpha V Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Integrin Alpha V Market CR5 and HHI
  11. 4.6.3 2025 Integrin Alpha V Tier 1, Tier 2, and Tier 3
5 Integrin Alpha V Market Size by Type
  1. 5.1 Global Integrin Alpha V Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Integrin Alpha V Revenue by Type (2021-2032)
  3. 5.3 Global Integrin Alpha V Revenue Market Share by Type (2021-2032)
6 Integrin Alpha V Market Size by Application
  1. 6.1 Global Integrin Alpha V Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Integrin Alpha V Revenue by Application (2021-2032)
  3. 6.3 Global Integrin Alpha V Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck & Co Inc
  2. 7.1.1 Merck & Co Inc Company Information
  3. 7.1.2 Merck & Co Inc Business Overview
  4. 7.1.3 Merck & Co Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck & Co Inc Integrin Alpha V Product Portfolio
  6. 7.1.5 Merck & Co Inc Recent Developments
  7. 7.2 Biogen Inc
  8. 7.2.1 Biogen Inc Company Information
  9. 7.2.2 Biogen Inc Business Overview
  10. 7.2.3 Biogen Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biogen Inc Integrin Alpha V Product Portfolio
  12. 7.2.5 Biogen Inc Recent Developments
  13. 7.3 Vascular Pharmaceuticals Inc
  14. 7.3.1 Vascular Pharmaceuticals Inc Company Information
  15. 7.3.2 Vascular Pharmaceuticals Inc Business Overview
  16. 7.3.3 Vascular Pharmaceuticals Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio
  18. 7.3.5 Vascular Pharmaceuticals Inc Recent Developments
  19. 7.4 SciFluor Life Sciences LLC
  20. 7.4.1 SciFluor Life Sciences LLC Company Information
  21. 7.4.2 SciFluor Life Sciences LLC Business Overview
  22. 7.4.3 SciFluor Life Sciences LLC Integrin Alpha V Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio
  24. 7.4.5 SciFluor Life Sciences LLC Recent Developments
  25. 7.5 Morphic Therapeutic Inc
  26. 7.5.1 Morphic Therapeutic Inc Company Information
  27. 7.5.2 Morphic Therapeutic Inc Business Overview
  28. 7.5.3 Morphic Therapeutic Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Morphic Therapeutic Inc Integrin Alpha V Product Portfolio
  30. 7.5.5 Morphic Therapeutic Inc Recent Developments
  31. 7.6 Merck KGaA
  32. 7.6.1 Merck KGaA Company Information
  33. 7.6.2 Merck KGaA Business Overview
  34. 7.6.3 Merck KGaA Integrin Alpha V Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck KGaA Integrin Alpha V Product Portfolio
  36. 7.6.5 Merck KGaA Recent Developments
  37. 7.7 MedImmune LLC
  38. 7.7.1 MedImmune LLC Company Information
  39. 7.7.2 MedImmune LLC Business Overview
  40. 7.7.3 MedImmune LLC Integrin Alpha V Revenue and Gross Margin (2021-2026)
  41. 7.7.4 MedImmune LLC Integrin Alpha V Product Portfolio
  42. 7.7.5 MedImmune LLC Recent Developments
  43. 7.8 Factor Therapeutics Ltd
  44. 7.8.1 Factor Therapeutics Ltd Company Information
  45. 7.8.2 Factor Therapeutics Ltd Business Overview
  46. 7.8.3 Factor Therapeutics Ltd Integrin Alpha V Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Factor Therapeutics Ltd Integrin Alpha V Product Portfolio
  48. 7.8.5 Factor Therapeutics Ltd Recent Developments
  49. 7.9 BioMAS Ltd
  50. 7.9.1 BioMAS Ltd Company Information
  51. 7.9.2 BioMAS Ltd Business Overview
  52. 7.9.3 BioMAS Ltd Integrin Alpha V Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioMAS Ltd Integrin Alpha V Product Portfolio
  54. 7.9.5 BioMAS Ltd Recent Developments
8 North America
  1. 8.1 North America Integrin Alpha V Revenue (2021-2032)
  2. 8.2 North America Integrin Alpha V Revenue by Type (2021-2032)
  3. 8.2.1 North America Integrin Alpha V Revenue by Type (2021-2026)
  4. 8.2.2 North America Integrin Alpha V Revenue by Type (2027-2032)
  5. 8.3 North America Integrin Alpha V Revenue Share by Type (2021-2032)
  6. 8.4 North America Integrin Alpha V Revenue by Application (2021-2032)
  7. 8.4.1 North America Integrin Alpha V Revenue by Application (2021-2026)
  8. 8.4.2 North America Integrin Alpha V Revenue by Application (2027-2032)
  9. 8.5 North America Integrin Alpha V Revenue Share by Application (2021-2032)
  10. 8.6 North America Integrin Alpha V Revenue by Country
  11. 8.6.1 North America Integrin Alpha V Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Integrin Alpha V Revenue by Country (2021-2026)
  13. 8.6.3 North America Integrin Alpha V Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Integrin Alpha V Revenue (2021-2032)
  2. 9.2 Europe Integrin Alpha V Revenue by Type (2021-2032)
  3. 9.2.1 Europe Integrin Alpha V Revenue by Type (2021-2026)
  4. 9.2.2 Europe Integrin Alpha V Revenue by Type (2027-2032)
  5. 9.3 Europe Integrin Alpha V Revenue Share by Type (2021-2032)
  6. 9.4 Europe Integrin Alpha V Revenue by Application (2021-2032)
  7. 9.4.1 Europe Integrin Alpha V Revenue by Application (2021-2026)
  8. 9.4.2 Europe Integrin Alpha V Revenue by Application (2027-2032)
  9. 9.5 Europe Integrin Alpha V Revenue Share by Application (2021-2032)
  10. 9.6 Europe Integrin Alpha V Revenue by Country
  11. 9.6.1 Europe Integrin Alpha V Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Integrin Alpha V Revenue by Country (2021-2026)
  13. 9.6.3 Europe Integrin Alpha V Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Integrin Alpha V Revenue (2021-2032)
  2. 10.2 China Integrin Alpha V Revenue by Type (2021-2032)
  3. 10.2.1 China Integrin Alpha V Revenue by Type (2021-2026)
  4. 10.2.2 China Integrin Alpha V Revenue by Type (2027-2032)
  5. 10.3 China Integrin Alpha V Revenue Share by Type (2021-2032)
  6. 10.4 China Integrin Alpha V Revenue by Application (2021-2032)
  7. 10.4.1 China Integrin Alpha V Revenue by Application (2021-2026)
  8. 10.4.2 China Integrin Alpha V Revenue by Application (2027-2032)
  9. 10.5 China Integrin Alpha V Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Integrin Alpha V Revenue (2021-2032)
  2. 11.2 Asia Integrin Alpha V Revenue by Type (2021-2032)
  3. 11.2.1 Asia Integrin Alpha V Revenue by Type (2021-2026)
  4. 11.2.2 Asia Integrin Alpha V Revenue by Type (2027-2032)
  5. 11.3 Asia Integrin Alpha V Revenue Share by Type (2021-2032)
  6. 11.4 Asia Integrin Alpha V Revenue by Application (2021-2032)
  7. 11.4.1 Asia Integrin Alpha V Revenue by Application (2021-2026)
  8. 11.4.2 Asia Integrin Alpha V Revenue by Application (2027-2032)
  9. 11.5 Asia Integrin Alpha V Revenue Share by Application (2021-2032)
  10. 11.6 Asia Integrin Alpha V Revenue by Country
  11. 11.6.1 Asia Integrin Alpha V Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Integrin Alpha V Revenue by Country (2021-2026)
  13. 11.6.3 Asia Integrin Alpha V Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Integrin Alpha V Revenue (2021-2032)
  2. 12.2 SAMEA Integrin Alpha V Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Integrin Alpha V Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Integrin Alpha V Revenue by Type (2027-2032)
  5. 12.3 SAMEA Integrin Alpha V Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Integrin Alpha V Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Integrin Alpha V Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Integrin Alpha V Revenue by Application (2027-2032)
  9. 12.5 SAMEA Integrin Alpha V Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Integrin Alpha V Revenue by Country
  11. 12.6.1 SAMEA Integrin Alpha V Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Integrin Alpha V Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Integrin Alpha V Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst